Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome‐wide association study

  • Zhanwei Wang
    University of Hawaii Cancer Center Honolulu Hawaii USA
  • Anuradha S Budhu
    Laboratory of Human Carcinogenesis, Liver Cancer Program, Center for Cancer Research National Cancer Institute Bethesda Maryland USA
  • Yi Shen
    University of Hawaii Cancer Center Honolulu Hawaii USA
  • Linda Lou Wong
    University of Hawaii Cancer Center Honolulu Hawaii USA
  • Brenda Y Hernandez
    University of Hawaii Cancer Center Honolulu Hawaii USA
  • Maarit Tiirikainen
    University of Hawaii Cancer Center Honolulu Hawaii USA
  • Xiaomei Ma
    Yale School of Public Health New Haven Connecticut USA
  • Melinda L Irwin
    Yale School of Public Health New Haven Connecticut USA
  • Lingeng Lu
    Yale School of Public Health New Haven Connecticut USA
  • Hongyu Zhao
    Yale School of Public Health New Haven Connecticut USA
  • Joseph K Lim
    Yale School of Medicine New Haven Connecticut USA
  • Tamar Taddei
    Yale School of Medicine New Haven Connecticut USA
  • Lopa Mishra
    Center for Translational Medicine, Department of Surgery The George Washington University Washington District of Columbia USA
  • Karen Pawlish
    New Jersey State Cancer Registry, New Jersey Department of Health Trenton New Jersey USA
  • Antoinette Stroup
    Rutgers Cancer Institute, and Rutgers School of Public Health New Brunswick New Jersey USA
  • Robert Brown
    Weill Cornell Medical College, and College of Physicians and Surgeons, Columbia University New York New York USA
  • Mindie H Nguyen
    Division of Gastroenterology and Hepatology Stanford University Medical Center Palo Alto California USA
  • Jill Koshiol
    Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA
  • Maria O Hernandez
    Laboratory of Human Carcinogenesis Center for Cancer Research, National Cancer Institute Bethesda Maryland USA
  • Marshonna Forgues
    Laboratory of Human Carcinogenesis Center for Cancer Research, National Cancer Institute Bethesda Maryland USA
  • Hwai‐I Yang
    Genomics Research Center, Academia Sinica Taipei Taiwan
  • Mei‐Hsuan Lee
    Institute of Clinical Medicine, National Yang Ming University Taipei Taiwan
  • Yu‐Han Huang
    Institute of Clinical Medicine, National Yang Ming University Taipei Taiwan
  • Motoki Iwasaki
    Division of Epidemiology Center for Public Health Sciences, National Cancer Center Tokyo Japan
  • Atsushi Goto
    Division of Epidemiology Center for Public Health Sciences, National Cancer Center Tokyo Japan
  • Shiori Suzuki
    Division of Epidemiology Center for Public Health Sciences, National Cancer Center Tokyo Japan
  • Koichi Matsuda
    Graduate School of Frontier Sciences, and Institute of Medical Science, University of Tokyo Tokyo Japan
  • Chizu Tanikawa
    Graduate School of Frontier Sciences, and Institute of Medical Science, University of Tokyo Tokyo Japan
  • Yoichiro Kamatani
    Graduate School of Frontier Sciences, and Institute of Medical Science, University of Tokyo Tokyo Japan
  • Dean Mann
    Department of Pathology University of Maryland School of Medicine Baltimore Maryland USA
  • Maria Guarnera
    Department of Pathology University of Maryland School of Medicine Baltimore Maryland USA
  • Kirti Shetty
    Department of Gastroenterology and Hepatology University of Maryland School of Medicine Baltimore Maryland USA
  • Claire E Thomas
    Division of Cancer Control and Population Sciences University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center Pittsburgh Pennsylvania USA
  • Jian‐Min Yuan
    Division of Cancer Control and Population Sciences University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center Pittsburgh Pennsylvania USA
  • Chiea Chuen Khor
    Genome Institute of Singapore, Agency for Science, Technology and Research Singapore Singapore
  • Woon‐Puay Koh
    Health Systems and Services Research, Duke‐NUS Medical School Singapore Singapore Singapore
  • Harvey Risch
    Yale School of Public Health New Haven Connecticut USA
  • Xin Wei Wang
    Laboratory of Human Carcinogenesis, Liver Cancer Program, Center for Cancer Research National Cancer Institute Bethesda Maryland USA
  • Herbert Yu
    University of Hawaii Cancer Center Honolulu Hawaii USA

抄録

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Chronic hepatitis C virus (HCV) infection, long‐term alcohol use, cigarette smoking, and obesity are the major risk factors for hepatocellular carcinoma (HCC) in the United States, but the disease risk varies substantially among individuals with these factors, suggesting host susceptibility to and gene–environment interactions in HCC. To address genetic susceptibility to HCC, we conducted a genome‐wide association study (GWAS).</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Two case‐control studies on HCC were conducted in the United States. DNA samples were genotyped using the Illumian microarray chip with over 710 000 single nucleotide polymorphisms (SNPs). We compared these SNPs between 705 HCC cases and 1455 population controls for their associations with HCC and verified our findings in additional studies.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In this GWAS, we found that two SNPs were associated with HCC at <jats:italic>P</jats:italic> < 5E‐8 and six SNPs at <jats:italic>P</jats:italic> < 5E‐6 after adjusting for age, sex, and the top three principal components (PCs). Five of the SNPs in chromosome 22q13.31, three in <jats:italic>PNPLA3</jats:italic> (rs2281135, rs2896019, and rs4823173) and two in <jats:italic>SAMM50</jats:italic> (rs3761472, rs3827385), were replicated in a small US case‐control study and a cohort study in Singapore. The associations remained significant after adjusting for body mass index and HCV infection. Meta‐analysis of multiple datasets indicated that these SNPs were significantly associated with HCC.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>SNPs in <jats:italic>PNPLA3</jats:italic> and <jats:italic>SAMM50</jats:italic> are known risk loci for nonalcoholic fatty liver disease (NAFLD) and are suspected to be associated with HCC. Our GWAS demonstrated the associations of these SNPs with HCC in a US population. Biological mechanisms underlying the relationship remain to be elucidated.</jats:p></jats:sec>

収録刊行物

  • JGH Open

    JGH Open 5 (12), 1363-1372, 2021-11-27

    Wiley

被引用文献 (1)*注記

もっと見る

参考文献 (52)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ